CapForce (OPGN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
12 Jun, 2026Executive summary
Transitioned from precision medicine to financial services and technology in 2024, focusing on listing sponsorship and consultancy for international companies.
Acquired Sun Investment Enterprises Limited (SIE) and its subsidiary iCapX in December 2025 to expand fintech and advisory capabilities.
Changed corporate name and ticker symbol in February 2026 following stockholder approval.
Financial highlights
No revenue recognized for the three months ended March 31, 2026 or 2025.
Net loss of $0.7 million for Q1 2026, compared to $0.4 million in Q1 2025.
Operating expenses increased 54% year-over-year to $0.8 million, mainly due to higher general and administrative costs.
Cash and cash equivalents were $0.1 million as of March 31, 2026, down from $0.5 million at year-end 2025.
Outlook and guidance
Plans to fund operations primarily through financing from AEI Capital until business becomes self-sustaining or investments are monetized.
$6.5 million of additional equity financing capacity remains available under an agreement with AEI Capital through December 2026.
Focus remains on revenue growth, platform development, and leveraging new fintech capabilities.
Latest events from CapForce
- 2025 revenue jumped to $30.2M, net income reached $23.6M, led by fintech and advisory growth.OPGN
Q4 20251 Jun 2026 - All seven proposals, including director elections and a name change, were approved by majority vote.OPGN
AGM 202623 Feb 2026 - Shareholders will vote on seven key proposals, including a new equity plan and company name change.OPGN
Proxy Filing6 Feb 2026 - Shareholders will vote on key governance, compensation, and structural changes, including a name change.OPGN
Proxy Filing26 Jan 2026 - Q2 2025 revenue reached $4.0M from listing sponsorship, with net income of $3.5M.OPGN
Q2 202531 Oct 2025 - OpGen posted $8.9M Q3 net income, exited diagnostics, and secured $9M equity funding for fintech pivot.OPGN
Q4 202313 Jun 2025 - OpGen's revenue collapsed and liquidity remains critical as it pursues a sale or strategic transaction.OPGN
Q2 202413 Jun 2025 - Revenue plunged 82% as OpGen pivots to survival mode amid insolvencies and urgent funding needs.OPGN
Q1 202413 Jun 2025